Du Pont Merck's I.V. Persantine
Executive Summary
Will be launched in early February. The drug will be sold directly to hospitals and radiopharmacies for $ 22 an ampule (2 ml) or $ 110 per five-ampule pack. Three to six ampules are used depending on a patient's weight. The drug was approved Dec. 13 as an alternative to exercise in thallium myocardial perfusion imaging in patients who cannot exercise adequately.